Results

Total Results: 1,167 records

Showing results for "diabetic".
Users also searched for: diabetes

221. Update of Comparative Effectiveness of Lipid-Modifying Agents | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
     May 17, 2013 - the NCEP-ATP III LDL-c target, LDL-c, HDL-c, and TC:HDL-c ratio Non–HDL-c and triglycerides in a diabetic … Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic

222. Can Physical Activity Improve the Health of Wheelchair Users? A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/physical-activity-wheelchair/protocol
     April 12, 2019 - Current Page Topic Timeline Sep. 7, 2018 Topic Initiated Apr. 12, 2019 Research Protocol Can Physical Activity Improve the Health of Wheelchair Users? A Systematic Review Research Protocol April 12, 2019 Download Main Document PDF 521.9 KB On June 20, 2019, amendments were made to this protocol. To …

223. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - based on meeting any of the following: primary hospital discharge diagnosis for diabetes mellitus or diabetic … Pharmacy data: One or more filled prescription for any of the following AHFS Classes for anti-diabetic … Outpatient: ≥2 visits for diabetes or diabetic complications (ICD-9 code 250.x) 3. … Transient cerebral ischemia Angina (Disease Index) ANGINA_PECTORIS OSCR 080.008 Diabetes 2, w/diabetic … angina pectoris ANGINA_PECTORIS OSCR 081.004 Diabetes 1, w/diabetic angina pectoris ANGINA_PECTORIS

224. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2.xlsx
     January 22, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

225. Pbt-Lsr-Draft-Ets-Rcts (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-rcts.xlsx
     March 15, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

226. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0.xlsx
     February 16, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

227. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
     January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

228. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
     January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

229. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
     February 16, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic

230. TND-0775-150722 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
     May 12, 2015 - TND-0775-150722 Treatments for Adults with Schizophrenia Nomination Summary Document Results of Topic Selection Process & Next Steps § This topic will go forw…

231. Future Research Needs for the Management of Gestational Diabetes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/gestational-diabetes-prioritizing-needs/research

232. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes Evidence-based Practice Center Technical Brief Protocol Project Title: Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes Initial Publication Date: Dec…

233. mmeta: Exact Bayesian Inference for Multivariate Meta-analysis of Binary Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mmeta/abstract
     February 11, 2014 - mmeta: Exact Bayesian Inference for Multivariate Meta-analysis of Binary Outcomes Abstract February 11, 2014 Topic Abstract Multivariate meta-analysis is useful in combining evidence from independent studies which involve several comparisons among groups based on a single outcome. We proposed a novel …

234. Hit-Patient-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
     June 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

235. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
     May 07, 2010 - Current Page Topic Timeline Mar. 16, 2010 Topic Initiated May. 7, 2010 Research Protocol Jun. 13, 2011 Systematic Review Oct. 7, 2011 Disposition of Comments Report Mar. 28, 2016 Surveillance Report Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARB…

236. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
     June 01, 2011 - Layout 1 Background Almost 75 million American adults— approximately one-third—have hypertension. The prevalence of hypertension increases with advancing age such that more than half of people 55 to 74 years old and approximately three-fourths of those age 75 years and older are affected. In addition to being the pr…

237. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-protocol.pdf
     April 01, 2022 - Postpartum Care for Women Up to One Year After Pregnancy Evidence-based Practice Center Systematic Review Protocol Project Title: Postpartum Care for Women Up to One Year After Pregnancy I. Background and Objectives for the Systematic Review In recent decades, the U.S. has witnessed a conside…

238. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy Evidence-based Practice Center Systematic Review Protocol Project Title: Postpartum Care for Women Up to One Year After Pregnancy Initial Publication Date: February 24, 2022 Amendment Date: April 25, 2022 (Amendments Details-see Section VI…

239. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - NCEP-ATP III LDL-c target, LDL-c, HDL-c, and TC:HDL-c ratio • Non–HDL-c and triglycerides in a diabetic … Fenofibrate, simvastatin and their combination in the management  of dyslipidaemia in type 2 diabetic

240. Case-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
     January 01, 2013 - 1 Comparative Effectiveness Review Number 99 Outpatient Case Management for Adults With Medical Illness and Complex Care Needs Executive Summary Background Chronic diseases are the leading cause of illness, disability, and death in the United States.1 Providing medical care for chronic illness is often compl…